Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Ethanol Sclerotherapy Before ART (Assisted Reproductive Technology) Cycle on Cumulative Live Birth Rate in Infertile Women With Endometrioma: A Randomized Controlled Trial

NCT05962775 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.

NCT NCT05962775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05962775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Ethanol Sclerotherapy Before ART (Assisted Reproductive Technology) Cycle on Cumulative Live Birth Rate in Infertile Women With Endometrioma: A Randomized Controlled Trial
Lead sponsor
Ankara University
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2023
Completion date
April 1, 2026
Enrollment
84 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

art, endometrioma, infertility, ivf, sclerotherapy